SKINNOQ: PMCF-study Using Novosyn® Quick Suture Material for Skin Closure

Sponsor
Aesculap AG (Industry)
Overall Status
Completed
CT.gov ID
NCT02680886
Collaborator
B.Braun Surgical SA (Industry)
100
2
22
50
2.3

Study Details

Study Description

Brief Summary

The aim of this study is to show that the performance of Novosyn® Quick suture material is comparable with other suture material used for skin closure. In order to show that, various safety and efficacy parameters have been selected. The outcome regarding these parameters will be evaluated by a quantitative summary of the available clinical data from the literature.

Condition or Disease Intervention/Treatment Phase
  • Device: Novosyn® Quick

Study Design

Study Type:
Observational
Actual Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Post-Marketing Clinical Follow-up (PMCF) Study for Skin Closure to Evaluate the Safety and Efficacy of Novosyn® Quick Suture Material. A Multicenter, International, Prospective, Observational Study
Actual Study Start Date :
Mar 1, 2016
Actual Primary Completion Date :
Oct 1, 2017
Actual Study Completion Date :
Jan 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Novosyn® Quick

Skin closure using rapid absorbable suture material

Device: Novosyn® Quick
Skin closure

Outcome Measures

Primary Outcome Measures

  1. Wound infection [3 months]

    Wound infection (Surgical site infection, SSI) is defined according to the definition of the US Centres for Disease Control and Prevention (CDC).

  2. Incidence of wound dehiscence [3 months postoperatively]

    A dehiscence of the skin which needs surgical treatment with re-closure

  3. Incidence of Tissue reaction / Inflammation [3 months postoperatively]

  4. Incidence of Suture removal [3 months postoperatively]

    Suture removal due to insufficient absorption

  5. Incidence of Re-suturing [3 months post-operatively]

    Re-Suturing due to dehiscence

  6. Cosmetic result [3 months post-operatively]

    Cosmetic result after surgery using the Patient and Observer Scar Assessment Scale (POSAS). Cosmetic result and the scar will be evaluated by the patient and the physician. Patient will rate the cosmetic outcome using the patient component of the Patient and Observer Scar Assessment Scale (POSAS). The physician will use the Observer component of the POSAS to assess the cosmetic outcome. Documentation of the scar will be performed 3 months postoperatively using photographs. Overall patient and observer satisfaction with the scar after 3 months postoperatively (POSAS).

  7. Assessment of the handling of the suture material [intraoperatively]

    Assessment of the handling of the suture material intra-operatively using a questionnaire including different dimensions (knot security, tensile strength, knot run down, tissue drag etc.) with 5 evaluations levels (excellent, very good, good, satisfied, poor).

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Year and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Pediatric and adult patients undergoing skin closure

  • Small linear minimally contaminated incision / lacerations on the trunk or extremities

  • Written informed consent

Exclusion Criteria:
  • Emergency surgery

  • Facial lacerations or incisions

  • Visible dirt in the wounds

  • Nonlinear shape

  • Patients taking medical consumption that might affect wound healing

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital Saint Louis La Rochelle France 17019
2 Klinikum der Johann-Wolfgang-Goethe Universität, Department for Pediatric Surgery and Pediatric Urology Frankfurt am Main Germany 60590

Sponsors and Collaborators

  • Aesculap AG
  • B.Braun Surgical SA

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Aesculap AG
ClinicalTrials.gov Identifier:
NCT02680886
Other Study ID Numbers:
  • AAG-O-H-1505
First Posted:
Feb 12, 2016
Last Update Posted:
May 4, 2018
Last Verified:
Jan 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Aesculap AG

Study Results

No Results Posted as of May 4, 2018